Publications '23 - Present

101. Le Minh, G., Lucky, S. S., Pervaiz, S., Ramadan, K., Yeong, J., Ong, S. T., Krishnan, V., Cheok, C. F., Chng, W. J., De Mel, S., Wang, X., Jeyasekharan, A. D., Tipgomut, C., Kong, L. R., Sabapathy, K., Chee, C. E., Itahana, K., Taneja, R., & Lee, S. C. (2025). Charting New Paths in Cancer Research: Insights from the Frontiers in Cancer Science Conference 2024. Cancer research, 85(15), 2784–2787. https://doi.org/10.1158/0008-5472.CAN-25-2205

100. Krueger, C., & Sabapathy, K. (2025). p53 prophylactic therapy for cancer prevention. Cell death and differentiation, 10.1038/s41418-025-01538-z. Advance online publication. https://doi.org/10.1038/s41418-025-01538-z

99. Lozano, G., Prives, C., & Sabapathy, K. (2025). Mutant p53 Gain of Function: Why Many See It, Why Some Do Not. Cancer discovery, 15(6), 1099–1104. https://doi.org/10.1158/2159-8290.CD-24-1638

98. Tabanifar, B., Lau, H., & Sabapathy, K. (2025). Tumor suppressor genes in the tumor microenvironment. Disease models & mechanisms, 18(3), dmm052049. https://doi.org/10.1242/dmm.052049

97. Spiegelberg, D., Hwang, L. A., Pua, K. H., Kumar, S. C., Koh, X. Y., Koh, X. H., Selvaraju, R. K., Sabapathy, K., Nestor, M., & Lane, D. (2025). Targeting mutant p53: Evaluation of novel anti-p53R175H monoclonal antibodies as diagnostic tools. Scientific reports, 15(1), 1000. https://doi.org/10.1038/s41598-024-83871-w

96. Li, D., Kok, C. Y. L., Wang, C., Ray, D., Osterburg, S., Dötsch, V., Ghosh, S., & Sabapathy, K. (2024). Dichotomous transactivation domains contribute to growth inhibitory and promotion functions of TAp73. Proceedings of the National Academy of Sciences of the United States of America, 121(21), e2318591121. https://doi.org/10.1073/pnas.2318591121

95. Lee, Y. F., Chen, L., Chew, V., Chow, E. K., Deng, L. W., Hunziker, W., Lee, A. S. G., Leong, G., Ngeow, J., Pervaiz, S., Sabapathy, K., Skanderup, A. J., Sundar, R., Tay, Y., Virshup, D. M., Wong, S. H., Tergaonkar, V., & Tam, W. L. (2024). Pushing the Frontiers of Cancer Research: Highlights from the Frontiers in Cancer Science Conference 2023. Cancer research, 84(8), 1195–1198. https://doi.org/10.1158/0008-5472.CAN-24-0721

94. Lau, H. S. H., Tan, V. K. M., Tan, B. K. T., Sim, Y., Quist, J., Thike, A. A., Tan, P. H., Pervaiz, S., Grigoriadis, A., & Sabapathy, K. (2023). Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers. NPJ breast cancer, 9(1), 84. https://doi.org/10.1038/s41523-023-00590-7

93. Tabanifar, B., Moorthy, A., Tsai, H. H., Kannan, S., Verma, C. S., & Sabapathy, K. (2023). JNK mediates cell death by promoting the ubiquitination of the apurinic/apyrimidinic endonuclease APE1. Cell reports, 42(9), 113123. https://doi.org/10.1016/j.celrep.2023.113123

92. Chai, D., Wang, X., Neeli, P., Zhou, S., Yu, X., Sabapathy, K., & Li, Y. (2023). DNA-delivered monoclonal antibodies targeting the p53 R175H mutant epitope inhibit tumor development in mice. Genes & diseases, 11(4), 100994. https://doi.org/10.1016/j.gendis.2023.04.027

91. Li, D., Neo, S. P., Gunaratne, J., & Sabapathy, K. (2023). EPLIN-β is a novel substrate of ornithine decarboxylase antizyme 1 and mediates cellular migration. Journal of cell science, 136(12), jcs260427. https://doi.org/10.1242/jcs.260427

90. Yap, J., Yuan, J., Ng, W. H., Chen, G. B., Sim, Y. R. M., Goh, K. C., Teo, J., Lim, T. Y. H., Goay, S. M., Teo, J. H. J., Lao, Z., Lam, P., Sabapathy, K., & Hu, J. (2023). BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes. Molecular cancer, 22(1), 125. https://doi.org/10.1186/s12943-023-01817-8

89. Brown, C. J., Li, Y., & Sabapathy, K. (2023). Editorial: Overcoming the cell membrane to target intracellular oncoproteins. Frontiers in oncology, 13, 1222095. https://doi.org/10.3389/fonc.2023.1222095